Non-Hodgkin Lymphoma Highlights From SOHO 2023 Non-Hodgkin Lymphoma Highlights From SOHO 2023

Dr Loretta Nastoupil highlights key data in non-Hodgkin lymphoma from SOHO 2023, including safety and efficacy of CAR-T therapies, bispecific antibodies, and mosunetuzumab retreatment.Medscape

Source: Medscape Today Headlines - September 27, 2023 Category: Consumer Health News Tags: Hematology-Oncology ReCAP Source Type: news